1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 21 Hits
  • 検索条件 : 絞込み (MeSH = Neovascularization, Pathologic / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 RBE(RCB1292) , TFK-1(RCB2537) Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
ヒト・動物細胞 HSC-2(RCB1945) Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
ヒト・動物細胞 NUGC-4(RCB1939) The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.
ヒト・動物細胞 HSC-2(RCB1945) , HSC-4(RCB1902) Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
ヒト・動物細胞 MKN45(RCB1001) Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
ヒト・動物細胞 MH7A(RCB1512) Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
ヒト・動物細胞 LLC(RCB0558) , OP9(RCB1124) LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain Tumors.
ヒト・動物細胞 B901L(RCB3530) MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
ヒト・動物細胞 Saos-2 Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
ヒト・動物細胞 LLC(RCB0558) , KLN205(RCB2623) , OP9(RCB1124) Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance.
ヒト・動物細胞 TGBC1TKB(RCB1129) Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.
ヒト・動物細胞 TKKK(RCB1907) Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
ヒト・動物細胞 GSU(RCB2278) , Kato III(RCB2088) , KE-97(RCB1435) , MKN45(RCB1001) , NUGC-4(RCB1939) A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
ヒト・動物細胞 U251(RCB0461) Combination therapy of cilengitide with belotecan against experimental glioblastoma.
ヒト・動物細胞 HuH-28(RCB1943) , TGBC1TKB(RCB1129) Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
ヒト・動物細胞 C2C12(RCB0987) Acetylcholinesterase inhibitors attenuate angiogenesis.
ヒト・動物細胞 RCN-9(RCB0511) Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.
ヒト・動物細胞 CACO-2(RCB0988) , PMF-ko14(RCB1426) 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor.
ヒト・動物細胞 LM8(RCB1450) Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma.
ヒト・動物細胞 Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.